SMS Pharmaceuticals informs about press release

26 Nov 2025 Evaluate
SMS Pharmaceuticals has informed that it enclosed the press release titled ‘SMS Pharmaceutical’s Associate Company, VKT Pharma, receives US FDA approval for its reformulated Ranitidine’. The above information will also be made available on the website of the Company at www.smspharma.com.

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

306.00 -5.60 (-1.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×